Global B2B Pharmaceutical Sourcing ยท Dossier Licensing ยท Named-Patient Access
๐Ÿ’ฌ WhatsApp ยท Sign in ยท Register

Oncology Cancer Care โ€” Manufacturers, Suppliers & Exporters

Can't find the Oncology Cancer Care product you need?
Send us an RFP โ€” our team sources it from verified manufacturers and reverts with quotes.
Send RFP โ†’

Browse Oncology Cancer Care products

Brentuximab Vedotin

Strength: 50 mg/vial

Form: Injection

Reference Brands: Adcetris (USA/EU)

View Details Get Enquiry

Brigatinib

Strength: 30mg, 90mg, 180mg

Form: Tablets

Reference Brands: Alunbrig (USA)

View Details Get Enquiry

Busulfan

Strength: 60mg

Form: Injection

Reference Brands: Myleran, Busulfex (US)

View Details Get Enquiry

Busulfan

Strength: Injection: 6 mg/mL; Tablet: 2 mg

Form: Injection (IV), Oral Tablet

Reference Brands: US: Busulfexยฎ (IV), Myleranยฎ (oral); EU: Busilvexยฎ (IV), Myleranยฎ (tablet)

View Details Get Enquiry

Cabazitaxel

Strength: 60mg

Form: Injection

Reference Brands: Jevtana (US/EU)

View Details Get Enquiry

Cabazitaxel

Strength: 60 mg/1.5 mL

Form: Injection

Reference Brands: Jevtanaยฎ(US & EU)

View Details Get Enquiry

Cabozantinib

Strength: 20 mg, 40 mg, 60 mg, 80mg, 100mg

Form: Tablets / Capsules

Reference Brands: Cometriq (USA), Cabometyx (USA/EU)

View Details Get Enquiry

Capecitabine

Strength: 500 mg

Form: Tablets

Reference Brands: Xeloda (US/EU)

View Details Get Enquiry

Capecitabine

Strength: 500 mg tablets 150 mg tablets

Form: Tablets

Reference Brands: Xelodaยฎ(EU & US)

View Details Get Enquiry

Capivasertib

Strength: 160 mg

Form: Tablets

Reference Brands: Truqap (USA)

View Details Get Enquiry

Capmatinib

Strength: 150 mg, 200 mg

Form: Tablets

Reference Brands: Tabrecta (USA/EU)

View Details Get Enquiry

Carbamazepine

Strength: 100 mg, 200 mg, 400 mg; Suspension: 100 mg/5 mL

Form: Oral Tablets and Suspension

Reference Brands: Tegretolยฎ, Tegretol XRยฎ, Carbatrolยฎ, Epitolยฎ (US & EU)

View Details Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.